AVEO PHARMACEUTICALS INC·4

Feb 28, 7:52 PM ET

Gyuris Jeno 4

4 · AVEO PHARMACEUTICALS INC · Filed Feb 28, 2012

Insider Transaction Report

Form 4
Period: 2012-02-24
Gyuris Jeno
SVP, Head of Research
Transactions
  • Sale

    Common Stock

    2012-02-24$13.68/sh1,500$20,52592,612 total
  • Sale

    Common Stock

    2012-02-28$13.08/sh1,000$13,08091,612 total
Footnotes (2)
  • [F1]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.60 to $13.75 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.05 to $13.11 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    rrd336463.xmlPrimary

    FORM 4